Monoacylcadaverines as substrates for both monoamine oxidase and diamine oxidase; low rates of activity. 1980

O Suzuki, and T Matsumoto, and M Oya, and Y Katsumata, and M Stepita-Klauco

Monoacetylcadaverine and monopropionylcadaverine were found to be substrates for both rat liver monoamine oxidase and hog kidney diamine oxidase, but all the Km-values for the oxidases were very high. The amines were common substrates for type A and type B monoamine oxidase.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008930 Mitochondria, Liver Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4) Liver Mitochondria,Liver Mitochondrion,Mitochondrion, Liver
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D010293 Pargyline A monoamine oxidase inhibitor with antihypertensive properties. Pargyline Hydrochloride,Hydrochloride, Pargyline
D002103 Cadaverine A foul-smelling diamine formed by bacterial DECARBOXYLATION of LYSINE. It is also an intermediate secondary metabolite in lysine-derived alkaloid biosynthetic pathways (e.g., QUINOLIZIDINES and LYCOPODIUM). 1,5-Pentanediamine,BioDex 1,Pentamethylenediamine,1,5 Pentanediamine
D003010 Clorgyline An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE. Clorgilin,Chlorgyline,Clorgiline
D003959 Diamines Organic chemicals which have two amino groups in an aliphatic chain. Diamine
D006631 Amine Oxidase (Copper-Containing) A group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide. Diamine Oxidase,Histaminase,Amine Oxidase, Copper-Containing,Copper Amine Oxidase,Diaminobenzidine Oxidase,Semicarbazide-Sensitive Amine Oxidase,Xylylene Diamine Oxidase,Amine Oxidase, Copper,Amine Oxidase, Copper Containing,Amine Oxidase, Semicarbazide-Sensitive,Copper-Containing Amine Oxidase,Diamine Oxidase, Xylylene,Oxidase, Copper Amine,Oxidase, Copper-Containing Amine,Oxidase, Diamine,Oxidase, Diaminobenzidine,Oxidase, Semicarbazide-Sensitive Amine,Oxidase, Xylylene Diamine,Semicarbazide Sensitive Amine Oxidase

Related Publications

O Suzuki, and T Matsumoto, and M Oya, and Y Katsumata, and M Stepita-Klauco
March 1962, Biochemical pharmacology,
O Suzuki, and T Matsumoto, and M Oya, and Y Katsumata, and M Stepita-Klauco
October 1960, Biochemical pharmacology,
O Suzuki, and T Matsumoto, and M Oya, and Y Katsumata, and M Stepita-Klauco
April 1973, Analytical biochemistry,
O Suzuki, and T Matsumoto, and M Oya, and Y Katsumata, and M Stepita-Klauco
November 1981, Life sciences,
O Suzuki, and T Matsumoto, and M Oya, and Y Katsumata, and M Stepita-Klauco
December 1985, Cancer,
O Suzuki, and T Matsumoto, and M Oya, and Y Katsumata, and M Stepita-Klauco
April 1957, The Journal of biological chemistry,
O Suzuki, and T Matsumoto, and M Oya, and Y Katsumata, and M Stepita-Klauco
January 1975, Biochemical pharmacology,
O Suzuki, and T Matsumoto, and M Oya, and Y Katsumata, and M Stepita-Klauco
January 1998, Journal of neural transmission. Supplementum,
O Suzuki, and T Matsumoto, and M Oya, and Y Katsumata, and M Stepita-Klauco
January 1989, Acta dermato-venereologica,
O Suzuki, and T Matsumoto, and M Oya, and Y Katsumata, and M Stepita-Klauco
October 1968, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!